OCD Trial, Recruiting (NCT06913738)

OCD Trial, Recruiting NCT06913738 Sponsor: AddiPsy Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT06913738 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with borderline personality disorder, confirmed by a structured clinical interview where you meet at least 5 out of 9 diagnostic criteria
You are willing and able to give written consent to take part in the study
You are covered by or registered with the French national health insurance system (Sécurité Sociale)

Who may not be able to join:

You are under 18 years old
You have been diagnosed with certain other conditions alongside borderline personality disorder, such as a psychotic disorder, intellectual disability, severe antisocial traits, a serious substance use problem that would make intensive therapy difficult, anorexia nervosa with physical health risks, or bipolar disorder currently in an acute manic phase
You are currently under a legal protection arrangement, such as guardianship or a court-appointed safeguard (confirm with trial site)
You are unable to cooperate with the study or complete questionnaires, whether filled in by yourself or by a clinician
You are not covered by or registered with the French national health insurance system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Martin Blay, M.D., M.Sc, AddiPsy

Phone: +33472943403

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06913738

Sponsor: AddiPsy

Phase: Not Applicable

Status: Recruiting

Condition: OCD

Trial contact: +33472943403

More information: https://clinicaltrials.gov/study/NCT06913738

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with borderline personality disorder, confirmed by a structured clinical interview where you meet at least 5 out of 9 diagnostic criteria
You are willing and able to give written consent to take part in the study
You are covered by or registered with the French national health insurance system (Sécurité Sociale)

Who may not be able to join:

You are under 18 years old
You have been diagnosed with certain other conditions alongside borderline personality disorder, such as a psychotic disorder, intellectual disability, severe antisocial traits, a serious substance use problem that would make intensive therapy difficult, anorexia nervosa with physical health risks, or bipolar disorder currently in an acute manic phase
You are currently under a legal protection arrangement, such as guardianship or a court-appointed safeguard (confirm with trial site)
You are unable to cooperate with the study or complete questionnaires, whether filled in by yourself or by a clinician
You are not covered by or registered with the French national health insurance system

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

AddiPsy

Registry

ClinicalTrials.gov

Start date

19 June 2024

Est. completion

1 December 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in BPD symptom severity (ZAN-BPD total score)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov